Abstract
Background & aims
Large, population-based studies that have included the full spectrum of cirrhosis estimating survival, taking into account time-at-risk are lacking. We aimed to report 1- and 5-year average survival rates for people with cirrhosis to be used in a clinical and healthcare policy setting.Methods
We used the Clinical Practice Research Datalink and linked English Hospital Episode Statistics to identify adult cases of cirrhosis from January 1998 to December 2009. We estimated 1- and 5-year survival according to whether time-at-risk was ambulatory or followed an emergency hospital admission related to liver disease, stratified by age, sex, and aetiology to be used in a clinical setting. We used a multivariate Cox-proportional hazards model with a time-varying variable, adjusted for Baveno IV stage of cirrhosis at diagnosis, age, aetiology, and sex.Results
We identified 5118 incident cases. Average survival probabilities at 1- and 5-years were 0.84 (95% CI 0.83-0.86) and 0.66 (95% CI 0.63-0.68) for the ambulatory group and 0.55 (95% CI 0.53-0.57) and 0.31 (95% CI 0.29-0.33) following hospitalisation, respectively. A hospital admission at diagnosis or subsequently for liver disease substantially impaired prognosis independent of stage of cirrhosis (HR=2.78, 95% CI 2.53, 3.06).Conclusions
Emergency hospitalisation for liver disease heralds a downturn in a patient's outlook independent of their stage of cirrhosis. Our results provide population-based clinically translatable estimates of prognosis for the purposes of healthcare delivery and planning and communication to patients.Full text links
Read article at publisher's site: https://doi.org/10.1016/j.jhep.2013.09.027
Read article for free, from open access legal sources, via Unpaywall: https://nottingham-repository.worktribe.com/preview/720765/Ratib_Manuscript_JHepatology.pdf
References
Articles referenced by this article (27)
Survival and prognostic indicators in compensated and decompensated cirrhosis.
Dig Dis Sci, (5):468-475 1986
MED: 3009109
Incidence, etiology and mortality of cirrhosis: a population-based cohort study.
Scand J Gastroenterol, (6):702-709 2012
MED: 22428859
Comorbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study.
Hepatology, (1):214-220 2008
MED: 18537190
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
Am J Gastroenterol, (5):1022-1031 2007
MED: 17313497
Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis.
Liver Int, (7):1033-1042 2010
MED: 20492502
Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver.
Gastroenterology, (5):1630-1635 1992
MED: 1426884
Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation
J Clin Gastronenterol 2002
All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study
Liver Int 2011
Trends in mortality after hospital admission for liver cirrhosis in an English population from 1968 to 1999.
Gut, (11):1615-1621 2005
MED: 15980061
Fatal pulmonary embolism in hospitalised patients: a necropsy review.
J Clin Pathol, (12):1254-1257 2004
MED: 15563663
Show 10 more references (10 of 27)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1016/j.jhep.2013.09.027
Article citations
Early screening for chronic liver disease: impact of a FIB-4 first integrated care pathway to identify patients with significant fibrosis.
Sci Rep, 14(1):20720, 05 Sep 2024
Cited by: 0 articles | PMID: 39237521 | PMCID: PMC11377570
Development and validation of a case definition to estimate the prevalence and incidence of cirrhosis in pan-Canadian primary care databases.
Can Liver J, 6(4):375-387, 20 Dec 2023
Cited by: 1 article | PMID: 38152327 | PMCID: PMC10751004
Hepatic Impairment as a Risk Factor for Drug Safety: Suitability and Comparison of Four Liver Scores as Screening Tools.
J Clin Med, 12(21):6814, 27 Oct 2023
Cited by: 0 articles | PMID: 37959279 | PMCID: PMC10649763
Rifaximin Reduces Risk of All-Cause Hospitalization in Cirrhotic Liver Transplant Candidates with Hepatic Encephalopathy.
J Clin Med, 12(21):6871, 31 Oct 2023
Cited by: 0 articles | PMID: 37959336 | PMCID: PMC10647372
Transient Elastography and Video Recovery Narrative Access to Support Recovery From Alcohol Misuse: Development of a Novel Intervention for Use in Community Alcohol Treatment Services.
JMIR Form Res, 7:e47109, 04 Oct 2023
Cited by: 1 article | PMID: 37792440 | PMCID: PMC10585443
Go to all (68) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Causes of death in people with liver cirrhosis in England compared with the general population: a population-based cohort study.
Am J Gastroenterol, 110(8):1149-1158, 14 Jul 2015
Cited by: 49 articles | PMID: 26169512
All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study.
Liver Int, 32(1):79-84, 06 Apr 2011
Cited by: 77 articles | PMID: 21745279
The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC).
PLoS One, 14(10):e0223253, 03 Oct 2019
Cited by: 2 articles | PMID: 31581237 | PMCID: PMC6776387
Mortality from cirrhosis: lack of progress over the last 35 years.
Gut, 54(11):1523-1526, 01 Nov 2005
Cited by: 11 articles | PMID: 16227356 | PMCID: PMC1774736
Review Free full text in Europe PMC
Funding
Funders who supported this work.
Medical Research Council (3)
Predicting the occurrence and mortality of upper gastrointestinal haemorrhage, a population based study
Dr Colin Crooks, University of Nottingham
Grant ID: G0802427
Grant ID: MR/K023195/1B
The UK Centre for Tobacco and Alcohol Studies (UKCTAS)
Professor John Britton, University of Nottingham
Grant ID: MR/K023195/1